Albert Matalon

Biosketch / Results /

Albert Matalon

Clinical Assistant Professor, Department of Medicine
Medicine

Contact Info

212/263-7239

Research Interests

Dialysis; Treament of Anemia; Prevention of dialysis-related infection; Familial Dysautonomia; Fabry Disease

Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study
Vemuri, Nirupama; Michelis, Michael F; Matalon, Albert
2012-02-05; 1471-2369,BMC nephrology - id: 140550, year: 2011

Renal transplantation in familial dysautonomia: report of two cases and review of the literature
Rekhtman, Yelena; Bomback, Andrew S; Nash, Martin A; Cohen, Scott D; Matalon, Albert; Jan, Dominique M; Kaufmann, Horacio; Axelrod, Felicia B; Radhakrishnan, Jai; Appel, Gerald B
2012-02-05; 1555-905x,Clinical journal of the American Society of Nephrology : CJASN - id: 138213, year: 2010

CaSR polymorphism Arg990Gly and response to calcimimetic agents in end-stage kidney disease patients with secondary hyperparathyroidism and in cell culture
Rothe, H; Shapiro, W; Sun, WY; Matalon, A
2012-02-05; 1741-0541,Personalized medicine - id: 90771, year: 2008

Genetic make-up of calcium-sensing receptor polymorphic position 990 and parameters of secondary hyperparathyroidism in haemodialysis centres from New York and Innsbruck
Rothe, H; Mayer, G; Eller, P; Matalon, A
2012-02-05; 0931-0509,Nephrology, dialysis, transplantation - id: 87123, year: 2007

Conversion to Lanthanum Carbonate Monotherapy Maintains Serum Phosphorus Control and Reduces Tablet Burden in Patients with Chronic Kidney Disease Stage 5
Vemuri N; Pratt R; Michelis M; Matalon A
2012-02-05; 0272-6386,American journal of kidney diseases - id: 112018, year: 2007